Association between cardiovascular diseases and pregnancy-induced hypertensive disorders in a population of Cameroonian women at Yaoundé: A case-control study

Autoři: Benedict P. Taa Nguimbis Esseme aff001;  Ebongue Mbondji aff001
Působiště autorů: Department of Public Health, School of Health Sciences, Catholic University of Central Africa, Yaounde, Center Region, Cameroon aff001;  Department of Health Systems and Policy, School of Health Systems and Public Health, University of Pretoria, Pretoria, Gauteng Province, South Africa Republic aff002
Vyšlo v časopise: PLoS ONE 14(12)
Kategorie: Research Article



Positive associations have been found between Hypertensive Disorders of Pregnancy gestational hypertension, preeclampsia and cardiovascular diseases within non-African populations, no data exist from sub-Saharan Africa. We aimed to assess this association in Cameroonian mothers.


We used a case-control study. Cases were women diagnosed with any arteriosclerotic cardiovascular disease between 2012 and 2017 at two major hospitals of Yaoundé. Controls were mothers of children who sought pediatric care at the Gyneco-obstetric hospital of Yaoundé, with no diagnosis of cardiovascular disease. We abstracted data from patient files to assess cardiovascular disease and used phone-based questionnaires to assess a prior history of Hypertensive Disorders of Pregnancy. We used logistic regression and propensity scores for data analysis.


Out of 1228 individuals selected, 173 cases and 339 controls participated in the study. We found no increased risk of cardiovascular diseases for women with a history of Hypertensive Disorders of Pregnancy (OR = 0.83, 95% CI, 0.51 to 1.34). Women with gestational hypertension had 2.33 (95% CI, 0.99 to 5.50) times the risk of women with no history of Hypertensive Disorders of Pregnancy, an inverse association was observed between preeclampsia and cardiovascular diseases (OR = 0.28, 95% CI, 0.10 to 0.72).


Cameroonian women with a history of gestational hypertension may have a higher risk of cardiovascular diseases. However, population-based studies with more accurate data on the exposure are needed.

Klíčová slova:

Blood pressure – Cardiovascular diseases – Cardiovascular diseases in women – Hypertension – Hypertensive disorders in pregnancy – Pediatrics – Preeclampsia – Women's health


1. Abalos E, Cuesta C, Carroli G, Qureshi Z, Widmer M, Vogel JP, et al. Pre‐eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG: An International Journal of Obstetrics & Gynaecology. 2014; 121: 14–24. doi: 10.1111/1471-0528.12629 24641531

2. Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013; 170: 1–7. doi: 10.1016/j.ejogrb.2013.05.005 23746796

3. Williams D. Pregnancy: a stress test for life. Curr Opin Obstet Gynecol. 2003; 15: 465–471. doi: 10.1097/00001703-200312000-00002 14624211

4. Roberts JM, Hubel CA. Pregnancy. A screening test for later life cardiovascular disease. Women’s Health Issues. 2010; 20: 304–307. doi: 10.1016/j.whi.2010.05.004 20800765

5. Bhattacharya S, Prescott GJ, Iversen L, Campbell DM, Smith WC, Hannaford PC. Hypertensive disorders of pregnancy and future health and mortality: A record linkage study. Pregnancy Hypertens. 2012; 2: 1–7. doi: 10.1016/j.preghy.2011.08.116 26104983

6. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007; 335: 974. doi: 10.1136/bmj.39335.385301.BE 17975258

7. McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. American heart journal. 2008; 156: 918–930. doi: 10.1016/j.ahj.2008.06.042 19061708

8. Lin Y-S, Tang C-H, Yang C-YC, Wu L-S, Hung S-T, Hwa H-L, et al. Effect of pre-eclampsia–eclampsia on major cardiovascular events among peripartum women in Taiwan. The American journal of cardiology. 2011; 107: 325–330. doi: 10.1016/j.amjcard.2010.08.073 21211611

9. Diehl CL, Brost BC, Hogan MC, Elesber AA, Offord KP, TURNER ST, et al. Preeclampsia as a risk factor for cardiovascular disease later in life: validation of a preeclampsia questionnaire. Am J Obstet Gynecol. 2008; 198: e11–3. doi: 10.1016/j.ajog.2007.09.038 18241822

10. Brown MC, Best KE, Pearce MS, Waugh J, Robson SC, Bell R. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. European journal of epidemiology. 2013; 28: 1–19. doi: 10.1007/s10654-013-9762-6 23397514

11. Greenland S. Basic Methods for Sensitivity Analysis of Biases. Int J Epidemiol. 1996; 25: 1107–1116. doi: 10.1093/ije/25.6.1107-a 9027513

12. Klemmensen AK, Olsen SF, Osterdal ML, Tabor A. Validity of preeclampsia-related diagnoses recorded in a national hospital registry and in a postpartum interview of the women. American Journal of Epidemiology. 2007; 166: 117–124. doi: 10.1093/aje/kwm139 17556761

13. VanderWeele TJ, Ding P. Sensitivity analysis in observational research. introducing the E‐value. Annals of Internal Medicine. 2017; 167: 268–274. doi: 10.7326/M16-2607 28693043

14. Institut National de la Statistique, ICF International (2012) République du Cameroun Enquête Démographique et de Santé et à Indicateurs Multiples. Calverton, Maryland, U.S.A: ICF International

15. Kestenbaum B, Seliger SL, Easterling TR, Gillen DL, Critchlow CW, Stehman-Breen CO, et al. Cardiovascular and thromboembolic events following hypertensive pregnancy. Am J Kidney Dis. 2003; 42: 982–989. doi: 10.1016/j.ajkd.2003.07.001 14582042

16. Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. The Lancet. 2005; 366: 1797–1803.

17. Valdiviezo C, Garovic VD, Ouyang P. Preeclampsia and hypertensive disease in pregnancy. Their contributions to cardiovascular risk. Clin Cardiol. 2012; 35: 160–165. doi: 10.1002/clc.21965 22389120

18. Lykke JA, Langhoff-Roos J, Sibai BM, Funai EF, Triche EW, Paidas MJ. Hypertensive Pregnancy Disorders and Subsequent Cardiovascular Morbidity and Type 2 Diabetes Mellitus in the Mother. Hypertension. 2009; 53: 944–951. doi: 10.1161/HYPERTENSIONAHA.109.130765 19433776

19. Black MH, Zhou H, Sacks DA, Dublin S, Lawrence JM, Harrison TN, et al. Hypertensive disorders first identified in pregnancy increase risk for incident prehypertension and hypertension in the year after delivery. J Hypertens. 2016; 34: 728–735. doi: 10.1097/HJH.0000000000000855 26809018

20. Agatisa PK, Ness RB, Roberts JM, Costantino JP, Kuller LH, McLaughlin MK. Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. American Journal of Physiology—Heart and Circulatory Physiology. 2004; 286: H1389–H1393. doi: 10.1152/ajpheart.00298.2003 15020302

21. Chambers JC, Fusi L, Malik IS, Haskard DO, de Swiet M, Kooner JS. Association of Maternal Endothelial Dysfunction With Preeclampsia. JAMA. 2001; 285: 1607–1612. doi: 10.1001/jama.285.12.1607 11268269

22. Goel A, Maski MR, Bajracharya S, Wenger JB, Zhang D, Salahuddin S, et al. Epidemiology and Mechanisms of De Novo and Persistent Hypertension in the Postpartum Period. Circulation. 2015; 132: 1726–1733. doi: 10.1161/CIRCULATIONAHA.115.015721 26416810

23. Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation. 2010; 122: 478–487. doi: 10.1161/CIRCULATIONAHA.109.895458 20644016

24. Paradisi G, Biaggi A, Savone R, Ianniello F, Tomei C, Caforio L, et al. Cardiovascular risk factors in healthy women with previous gestational hypertension. J Clin Endocrinol Metab. 2006; 91: 1233–1238. doi: 10.1210/jc.2005-1337 16434462

25. Girouard J, Giguère Y, Moutquin J-M, Forest J-C. Previous Hypertensive Disease of Pregnancy Is Associated With Alterations of Markers of Insulin Resistance. Hypertension. 2007; 49: 1056–1062. doi: 10.1161/HYPERTENSIONAHA.107.087528 17389257

26. Sattar N, Bendomir A, Berry C, Shepherd J, Greer IA, Packard CJ. Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstetrics and gynecology. 1997; 89: 403–408. doi: 10.1016/S0029-7844(96)00514-5 9052594

27. Magnussen EB, Vatten LJ, Smith GD, Romundstad PR. Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors. Obstetrics and gynecology. 2009; 114: 961–970. doi: 10.1097/AOG.0b013e3181bb0dfc 20168095

Článek vyšel v časopise


2019 Číslo 12
Nejčtenější tento týden